ACS Medicinal Chemistry Letters
Letter
(15) Varadarajulu, J.; Schmitt, A.; Falkai, P.; Alsaif, M.; Turck, C. W.;
Martins-de-Souza, D. Differential expression of HINT1 in schizophrenia
brain tissue. Eur. Arch Psychiatry Clin Neurosci. 2012, 262, 167−172.
(16) Barbier, E.; Zapata, A.; Oh, E.; Liu, Q.; Zhu, F.; Undie, A.;
Shippenberg, T.; Wang, J. B. Supersensitivity to amphetamine in protein
kinase-C interacting protein/HINT1 knockout mice. Neuropsychophar-
macology 2007, 32, 1774−1782.
(17) Jackson, K. J.; Wang, J. B.; Barbier, E.; Damaj, M. I.; Chen, X. The
histidine triad nucleotide binding 1 protein is involved in nicotine
reward and physical nicotine withdrawal in mice. Neurosci. Lett. 2013,
550, 129−133.
Association through a contract with Hauptman-Woodward
Medical Research Institute. Isothermal titration calorimetry
was carried out using an ITC-200 microcalorimeter, funded by
the NIH Shared Instrumentation Grant S10-OD017982.
ABBREVIATIONS
■
hHint1, human histidine triad nucleotide binding protein 1;
NMDAR, N-methyl D-aspartate receptor; MOR, μ-opioid
receptor; CNS, central nervous system; DBU, 1,8-diazabicyclo-
[5.4.0] undec-7-ene; TFA, trifluoroacetic acid; MTPI, methyl-
triphenoxyphosphonium iodide; DMA, dimethyl acetamide;
EDC, 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide
(18) Rodríguez-Munoz, M.; San
́
chez-Blaz
́
quez, P.; Vicente-San
, J. The histidine triad
́
chez,
̃
A.; Bailon
́
, C.; Martín-Aznar, B.; Garzon
́
nucleotide-binding protein 1 supports mu-opioid receptor-glutamate
NMDA receptor cross-regulation. Cell. Mol. Life Sci. 2011, 68, 2933−
2949.
REFERENCES
■
(19) Guang, W.; Wang, H.; Su, T.; Weinstein, I. B.; Wang, J. B. Role of
mPKCI, a novel mu-opioid receptor interactive protein, in receptor
desensitization, phosphorylation, and morphine-induced analgesia. Mol.
Pharmacol. 2004, 66, 1285−1292.
(20) Kawasumi, M.; Nghiem, P. Chemical genetics: elucidating
biological systems with small-molecule compounds. J. Invest. Dermatol.
2007, 127, 1577−1584.
(21) Duckworth, B. P.; Geders, T. W.; Tiwari, D.; Boshoff, H. I.;
Sibbald, P. A.; Barry, C. E.; Schnappinger, D.; Finzel, B. C.; Aldrich, C. C.
Bisubstrate adenylation inhibitors of biotin protein ligase from
Mycobacterium tuberculosis. Chem. Biol. 2011, 18, 1432−1441.
(22) Bai, G.; Feng, B.; Wang, J. B.; Pozharski, E.; Shapiro, M. Studies on
ligand binding to histidine triad nucleotide binding protein 1. Bioorg.
Med. Chem. 2010, 18, 6756−6762.
(23) Dawadi, S.; Viswanathan, K.; Boshoff, H. I.; Barry, C. E.; Aldrich,
C. C. Investigation and conformational analysis of fluorinated
nucleoside antibiotics targeting siderophore biosynthesis. J. Org.
Chem. 2015, 80, 4835−4850.
(1) Liu, Q.; Puche, A. C.; Wang, J. B. Distribution and expression of
protein kinase C interactive protein (PKCI/HINT1) in mouse central
nervous system (CNS). Neurochem. Res. 2008, 33, 1263−1276.
(2) Garzon
́
, J.; Herrero-Labrador, R.; Rodríguez-Munoz, M.; Shah, R.;
̃
Vicente-Sanchez, A.; Wagner, C. R.; Sanchez-Blazquez, P. HINT1
́
́
́
protein: a new therapeutic target to enhance opioid antinociception and
block mechanical allodynia. Neuropharmacology 2015, 89, 412−423.
(3) Chou, T. F.; Baraniak, J.; Kaczmarek, R.; Zhou, X.; Cheng, J.;
Ghosh, B.; Wagner, C. R. Phosphoramidate pronucleotides: a
comparison of the phosphoramidase substrate specificity of human
and Escherichia coli histidine triad nucleotide binding proteins. Mol.
Pharmaceutics 2007, 4, 208−217.
(4) Wang, J.; Fang, P.; Schimmel, P.; Guo, M. Side chain independent
recognition of aminoacyl adenylates by the Hint1 transcription
suppressor. J. Phys. Chem. B 2012, 116, 6798−6805.
(5) Zhou, X.; Chou, T. F.; Aubol, B. E.; Park, C. J.; Wolfenden, R.;
Adams, J.; Wagner, C. R. Kinetic mechanism of human histidine triad
nucleotide binding protein 1. Biochemistry 2013, 52, 3588−3600.
(6) Lima, C. D.; Klein, M. G.; Hendrickson, W. A. Structure-based
analysis of catalysis and substrate definition in the HIT protein family.
Science 1997, 278, 286−290.
(7) Murakami, E.; Tolstykh, T.; Bao, H.; Niu, C.; Steuer, H. M.; Bao,
D.; Chang, W.; Espiritu, C.; Bansal, S.; Lam, A. M.; Otto, M. J.; Sofia, M.
J.; Furman, P. A. Mechanism of activation of PSI-7851 and its
diastereoisomer PSI-7977. J. Biol. Chem. 2010, 285, 34337−34347.
(8) Drontle, D. P.; Wagner, C. R. Designing a pronucleotide stratagem:
lessons from amino acid phosphoramidates of anticancer and antiviral
pyrimidines. Mini-Rev. Med. Chem. 2004, 4, 409−419.
(9) Li, S.; Jia, Y.; Jacobson, B.; McCauley, J.; Kratzke, R.; Bitterman, P.
B.; Wagner, C. R. Treatment of breast and lung cancer cells with a N-7
benzyl guanosine monophosphate tryptamine phosphoramidate
pronucleotide (4Ei-1) results in chemosensitization to gemcitabine
and induced eIF4E proteasomal degradation. Mol. Pharmaceutics 2013,
10, 523−531.
(10) Abraham, T. W.; Kalman, T. I.; McIntee, E. J.; Wagner, C. R.
Synthesis and biological activity of aromatic amino acid phosphor-
amidates of 5-fluoro-2′-deoxyuridine and 1-beta-arabinofuranosylcyto-
sine: evidence of phosphoramidase activity. J. Med. Chem. 1996, 39,
4569−4575.
(11) Chou, T. F.; Wagner, C. R. Lysyl-tRNA synthetase-generated
lysyl-adenylate is a substrate for histidine triad nucleotide binding
proteins. J. Biol. Chem. 2007, 282, 4719−4727.
(24) Gruber, B. A.; Leonard, N. J. Dynamic and static quenching of
1,N6-ethenoadenine fluorescence in nicotinamide 1,N6-ethenoadenine
dinucleotide and in 1,N6-etheno-9-(3-(indol-3-yl) propyl) adenine.
Proc. Natl. Acad. Sci. U. S. A. 1975, 72, 3966−3969.
(25) Dolot, R.; Ozga, M.; Włodarczyk, A.; Krakowiak, A.; Nawrot, B. A
new crystal form of human histidine triad nucleotide-binding protein 1
(hHINT1) in complex with adenosine 5′-monophosphate at 1.38 Å
resolution. Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 2012,
68, 883−888.
(26) Snyder, P. W.; Mecinovic, J.; Moustakas, D. T.; Thomas, S. W.;
́
Harder, M.; Mack, E. T.; Lockett, M. R.; Heroux, A.; Sherman, W.;
Whitesides, G. M. Mechanism of the hydrophobic effect in the
biomolecular recognition of arylsulfonamides by carbonic anhydrase.
Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 17889−17894.
(27) Breiten, B.; Lockett, M. R.; Sherman, W.; Fujita, S.; Al-Sayah, M.;
Lange, H.; Bowers, C. M.; Heroux, A.; Krilov, G.; Whitesides, G. M.
Water networks contribute to enthalpy/entropy compensation in
protein-ligand binding. J. Am. Chem. Soc. 2013, 135, 15579−15584.
(28) Persch, E.; Dumele, O.; Diederich, F. Molecular recognition in
chemical and biological systems. Angew. Chem., Int. Ed. 2015, 54, 3290−
3327.
(12) Lee, Y. N.; Nechushtan, H.; Figov, N.; Razin, E. The function of
lysyl-tRNA synthetase and Ap4A as signaling regulators of MITF activity
in FcepsilonRI-activated mast cells. Immunity 2004, 20, 145−151.
(13) Li, H.; Zhang, Y.; Su, T.; Santella, R. M.; Weinstein, I. B. Hint1 is a
haplo-insufficient tumor suppressor in mice. Oncogene 2006, 25, 713−
721.
(14) Wang, L.; Zhang, Y.; Li, H.; Xu, Z.; Santella, R. M.; Weinstein, I. B.
Hint1 inhibits growth and activator protein-1 activity in human colon
cancer cells. Cancer Res. 2007, 67, 4700−4708.
E
ACS Med. Chem. Lett. XXXX, XXX, XXX−XXX